BridgeBio · 5 hours ago
Director, Patient Identification Programs
San Francisco - 1800 Owens
Full-time
Hybrid
Director/Executive
$230K/yr - $270K/yr
8+ years expBridgeBio is pioneering innovative approaches in biotech to advance treatments for rare diseases. The Director of Patient Identification Programs will lead the design and implementation of strategies to enhance patient diagnosis and access to therapies, collaborating across various departments and external partners.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Develop and execute a comprehensive patient identification strategy aligned with commercial launch and pipeline priorities, disease areas, and corporate objectives
Serve as the enterprise subject-matter expert on patient identification, diagnostic pathways, and unmet diagnostic needs
Lead and mentor cross-functional contributors to patient identification programs
Design and operationalize patient identification programs focused on (pre-)commercial stage and – to a lesser extent – clinical stage programs
Leverage initiatives such as diagnostic algorithms, EHR-based identification, biomarker screening, genetic testing programs, and referral pathways
Ensure programs are scalable, compliant, and adaptable across geographies and indications
Partner closely with Commercial, Medical Affairs, Data Science, Market Access, Regulatory, Legal/Compliance, Clinical Development teams
Align patient identification efforts with launch readiness plans
Provide strategic input into evidence generation and disease education initiatives
Leverage real-world data (claims, EHR, genomics, registries) to identify patient populations and optimize identification approaches
Define success metrics, dashboards, and KPIs to measure program impact and inform continuous improvement
Translate data insights into actionable recommendations for internal stakeholders
Build and manage relationships with diagnostic companies, health systems, laboratories, advocacy groups, digital health vendors, and data partners
Evaluate and onboard innovative technologies and vendors to enhance patient identification capabilities
Represent the company externally as a thought leader in patient identification and rare disease diagnosis
Ensure all programs adhere to applicable regulatory, privacy, and compliance requirements (e.g., HIPAA, GDPR, promotional regulations)
Partner with Legal and Compliance to design ethical, patient-centric programs that prioritize trust and transparency
Qualification
Required
Advanced degree (PhD, MD, PharmD, MPH, MS) or equivalent experience in life sciences, healthcare, or a related field
8–12+ years of experience in biopharma, healthcare, diagnostics, or health technology, with significant experience in patient identification and related functions
Proven experience designing, building, and operating complex, cross-functional programs and influencing senior stakeholders
Strong understanding of diagnostic pathways, rare disease ecosystems, and real-world data sources
Preferred
Experience in rare disease, precision medicine, or genetically defined conditions
Familiarity with digital health tools, advanced analytics, and AI-enabled identification approaches
Experience working with external partners and vendors in a highly regulated environment
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
201-500 employees
H1B Sponsorship
BridgeBio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (5)
2023 (4)
2022 (4)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Post Ipo Debt· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Leadership Team
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
Neil Kumar
CEO and Founder
Recent News
BioWorld Financial Watch
2026-01-17
Company data provided by crunchbase